Hunan Warrant Pharmaceutical Co. Ltd. A (688799) — Cash Flow-to-Debt Ratio
Hunan Warrant Pharmaceutical Co. Ltd. A (688799) has a Cash Flow-to-Debt Ratio of 0.22x as of December 2024, meaning its operating cash flow of CN¥142.23 Million could theoretically repay 0% of its total liabilities (CN¥637.06 Million) in one year. See 688799 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hunan Warrant Pharmaceutical Co. Ltd. A Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Hunan Warrant Pharmaceutical Co. Ltd. A across 6 annual periods. Also explore Hunan Warrant Pharmaceutical Co. Ltd. A annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Hunan Warrant Pharmaceutical Co. Ltd. A (2019–2024)
Year-by-year debt coverage analysis for Hunan Warrant Pharmaceutical Co. Ltd. A. For market capitalisation and broader financial context, see Hunan Warrant Pharmaceutical Co. Ltd. A market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.22x | CN¥142.23 Million | CN¥637.06 Million | ▼ -57.5% |
| 2023 | 0.52x | CN¥214.44 Million | CN¥408.70 Million | ▲ +18.1% |
| 2022 | 0.44x | CN¥155.65 Million | CN¥350.35 Million | ▲ +23.2% |
| 2021 | 0.36x | CN¥114.72 Million | CN¥318.07 Million | ▼ -11.1% |
| 2020 | 0.41x | CN¥104.66 Million | CN¥258.07 Million | ▲ +3.7% |
| 2019 | 0.39x | CN¥116.66 Million | CN¥298.27 Million | — |